- In November 2022, Boston Scientific announced its agreement to acquire Apollo Endosurgery, Inc., a leader in minimally invasive surgical devices, particularly in the area of endoscopic suturing and tissue closure. This acquisition will enhance Boston Scientific's capabilities in automated suturing and expand its portfolio of advanced endoscopic solutions. By integrating Apollo’s expertise, the company aims to offer more innovative, efficient tools for surgical procedures. The benefits include improved surgical precision, reduced patient recovery times, and greater overall efficiency in minimally invasive surgeries, further strengthening Boston Scientific’s leadership in the automated suturing market.
Frequently Asked Questions
Companies such as Medtronic (Ireland), Boston Scientific Corporation (U.S.), BD (U.S.), LSI Solutions (U.S.), Medical Device Business Service, Inc. (U.S.), Crunchbase Inc. (U.S.).
In November 2022, Boston Scientific has agreed to acquire Apollo Endosurgery, Inc., enhancing its capabilities in automated suturing and minimally invasive solutions, offering improved surgical precision, faster recovery, and greater efficiency in surgical procedures.
The countries covered in the automated suturing devices market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
